New SVP of R&D for Amylin

Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) said it promoted Christian Weyer to SVP of R&D from VP of medical development. Weyer replaces Orville Kolterman, who becomes SVP and CMO, a newly created posi...